Earnings History Data for Ascendis Pharma A/S (ASND) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology, central nervous system disorders, infectious diseases and diabetes. Its technology includes TransCon which develop prodrug therapies. Ascendis Pharma A/S is based in Denmark.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
25-08-2021 AH 4:00 PM ET
(Aug 25)
ASND Ascendis Pharma A/S 6,570 -3.01 -2.75 -2.17 Ascendis Pharma EPS beats by $0.14
[8/25/2021 4:23 PM]
149.09 25.43 
(20.56%)
150.63 26.97 
(21.80%)
109.36 - 183.98 2,136,992 200,000 57,137
27-05-2021 AH 4:00 PM ET
(May 27)
ASND Ascendis Pharma A/S 7,140 -1.41 -2.06 -1.46 Ascendis Pharma reports Q1 results
[5/27/2021 4:03 PM]
134.00 -2.19 
(-1.61%)
136.19 0.0 
(0.00%)
119.11 - 183.98 238,156 190,000 893
10-03-2021 AH 4:00 PM ET
(Mar 10)
ASND Ascendis Pharma A/S 7,590 -3.15 -1.84 -1.88 149.46 5.47 
(3.80%)
143.99 0.0 
(0.00%)
92.00 - 183.98 130,101 232,100 3,913
11-11-2020 AH 4:00 PM ET
(Nov 11)
ASND Ascendis Pharma A/S 8,990 -2.70 -1.80 -0.59 Ascendis Pharma reports Q3 results
[11/11/2020 4:06 PM]
166.37 6.37 
(3.98%)
160.00 0.0 
(0.00%)
92.00 - 178.26 201,664 150,823 6,498
27-08-2020 AH 4:00 PM ET
(Aug 27)
ASND Ascendis Pharma A/S 7,360 -2.17 -1.66 -1.40 Ascendis Pharma EPS misses by €0.50, misses on revenue
[8/27/2020 4:13 PM]
137.59 -0.23 
(-0.17%)
0.0 0.0 
(0.00%)
90.06 - 158.93 76,975 137,295 0
19-05-2020 AH 4:00 PM ET
(May 19)
ASND Ascendis Pharma A/S 6,710 -1.46 -1.49 -1.41 Ascendis Pharma EPS beats by €0.01, beats on revenue
[5/19/2020 4:07 PM]
146.20 3.01 
(2.10%)
142.50 -3.66 
(-2.50%)
90.06 - 150.00 360,017 260,659 0